Quick answer: latest quarter results, by ticker or company name

Reported Q: Q4 2024 Rev YoY: +0.8% EPS YoY: -24.5% Move: -2.56%

Agilent Technologies Inc

0HAV.L

$127.33 -2.56%

Exchange LSE Sector Healthcare Industry Medical Pharmaceuticals

Q4 2024

Published: Dec 20, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for 0HAV.L

Reported

Report Date

Dec 20, 2024

Quarter Q4 2024

Revenue

1.70B

YoY: +0.8%

EPS

1.22

YoY: -24.5%

Market Move

-2.56%

Previous quarter: Q3 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

Revenue of $1.70B up 0.8% year-over-year
EPS of $1.22 decreased by 24.5% from previous year
Gross margin of 53.9%
Net income of 351.00M
"N/A" - N/A

0HAV.L

Company 0HAV.L

Period Q4 2024

Currency USD

Report Type Quarterly Earnings

Generated Feb 9, 2026

Executive Summary

- Agilent delivered Q4 2024 revenue of USD 1.701 billion, up 7.8% quarter-on-quarter and marginally higher year-over-year, supported by solid demand across core life sciences instrumentation. Gross profit of USD 916 million produced a gross margin of 53.85%, reinforcing the company’s ability to sustain value even as the mix shifts.

Key Performance Indicators

Revenue

Increasing

1.70B

QoQ: 7.79% | YoY: 0.77%

Gross Profit

Increasing

916.00M

53.85% margin

QoQ: 7.13% | YoY: 0.11%

Operating Income

Stable

408.00M

QoQ: 22.52% | YoY: 0.00%

Net Income

Decreasing

351.00M

QoQ: 24.47% | YoY: -26.11%

EPS

Decreasing

1.23

QoQ: 26.80% | YoY: -24.54%

Revenue Trend

Margin Analysis

Financial Highlights

- Revenue: USD 1.701B; YoY +0.77%; QoQ +7.79%
- Gross Profit: USD 916M; Gross Margin 53.85%; YoY +0.11%; QoQ +7.13%
- Operating Income: USD 408M; Operating Margin 23.99%; YoY 0.00%; QoQ +22.52%
- Net Income: USD 351M; Net Margin 20.63%; YoY -26.11%; QoQ +24.47%
- EPS (Basic): USD 1.23; EPS (Diluted): USD 1.22; YoY -24.54%; QoQ +26.80%
- Operating Cash Flow: USD 481M; Free Cash Flow: USD 388M
- Cash at End of Period: USD 1.329B; Net Debt: USD 2.061B; Total Debt: USD 3.39B
- Dividend Payout: USD 68M in dividends; Dividend Payout Ratio: 19.4%
- Key efficiency/position metrics: Current ratio 2.09, Quick ratio 1.58, Cash ratio 0.70; ROA 2.94%, ROE 5.95%, ROCE 4.26%
- Balance sheet: Total assets USD 11.846B; Total liabilities USD 5.948B; Total equity USD 5.898B

Income Statement

Metric	Value	YoY Change	QoQ Change
Revenue	1.70B	0.77%	7.79%
Gross Profit	916.00M	0.11%	7.13%
Operating Income	408.00M	0.00%	22.52%
Net Income	351.00M	-26.11%	24.47%
EPS	1.23	-24.54%	26.80%

Key Financial Ratios

Gross Profit Margin

Good

54.40%

Gross profit margin is healthy and competitive within industry standards

Operating Profit Margin

Excellent

25.20%

Operating margin is exceptional, indicating strong pricing power and operational efficiency

Net Profit Margin

Excellent

20.60%

Net profit margin is exceptional, indicating strong pricing power and operational efficiency

Return on Assets

Weak

2.94%

Return on assets suggests inefficient capital allocation

Return on Equity

Fair

5.95%

Return on equity is acceptable but below top-tier companies

Current Ratio

Healthy

2.09

Current ratio shows adequate liquidity to meet short-term obligations

Debt to Equity

Elevated

0.61

Debt-to-equity shows significant leverage, monitor debt levels

P/E Ratio

Growth

26.69x

Elevated P/E suggests growth expectations or premium valuation

Price to Book

High Premium

6.35x

Very high premium suggests asset-light business model or lofty expectations

Historical Earnings Comparison

Period	Revenue ($M)	EPS ($)	YoY Growth	Report
Q3 2025	1,738.00	1.18	+10.1%	View
Q2 2025	1,668.00	0.75	+6.0%	View
Q1 2025	1,681.00	1.11	+1.4%	View
Q4 2024	1,701.00	1.22	+0.8%	View
Q3 2024	1,578.00	0.97	-5.6%	View

0HAV.L

Agilent Technologies Inc

Q3 2025 Report

Agilent Technologies Inc (0HAV.L) QQ3 2025 Financial Analysis: Solid Q3 Performance, Stable Margin Power, and Robust Free Cash Flow in a Dynamic Lab I...

Read full report

0HAV.L

Agilent Technologies Inc

Q2 2025 Report

Agilent Technologies Inc (0HAV.L) QQ2 2025 Results – Revenue Growth Amid Margin Pressures and Strong Cash Flow...

Read full report

0HAV.L

Agilent Technologies Inc

Q1 2025 Report

Agilent Technologies Inc (0HAV.L) QQ1 2025 Results: Modest Revenue Growth, Robust Cash Flow, and Healthy Margins in Life Sciences Instrumentation...

Read full report

0HAV.L

Agilent Technologies Inc

Q3 2024 Report

Agilent Technologies Inc (0HAV.L) QQ3 2024 Results Analysis: Resilient Life Sciences Instrumentation Demand, Margin Expansion, and Strong Free Cash Fl...

Read full report

Agilent Technologies Inc (0HAV.L) Q4 2024 Earnings Report

Company Status Snapshot

Earnings Highlights

Executive Summary

Key Performance Indicators

Revenue Trend

Margin Analysis

Financial Highlights

Income Statement

Key Financial Ratios

Management Insights Available for Members

Peer Comparison Available for Members

Investment Outlook & SWOT Available for Members

Historical Earnings Comparison

More 0HAV.L Quarterly Reports

0HAV.L

0HAV.L

0HAV.L

0HAV.L

Q4 2024 Reports in Healthcare Sector

0HBH.L

0HOY.L

Related Financial Data

Sector Analysis: Healthcare

0HAV.L Full Profile

0HAV.L Financial Statements

Earnings Calendar